Healthcare provider profile · identity verified

Kipton Lynn Anderson, MD

Family Practice · COLUMBUS, NE · NPI 1124098710

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	665	121
Atorvastatin Calcium	Atorvastatin Calcium	494	107
Metformin Hcl	Metformin Hcl	368	71
Amlodipine Besylate	Amlodipine Besylate	366	79
Lisinopril	Lisinopril	350	78
Pantoprazole Sodium	Pantoprazole Sodium	332	67
Simvastatin	Simvastatin	302	77
Gabapentin	Gabapentin	290	48
Omeprazole	Omeprazole	285	58
Metoprolol Succinate	Metoprolol Succinate	277	62
Escitalopram Oxalate	Escitalopram Oxalate	272	43
Hydrochlorothiazide	Hydrochlorothiazide	256	56
Furosemide	Furosemide	232	41
Glimepiride	Glimepiride	230	46
Tamsulosin Hcl	Tamsulosin Hcl	219	42
Potassium Chloride	Potassium Chloride	206	34
Tramadol Hcl	Tramadol Hcl	189	42
Eliquis	Apixaban	176	29
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	166	165
Losartan Potassium	Losartan Potassium	166	47
Metoprolol Tartrate	Metoprolol Tartrate	156	32
Meloxicam	Meloxicam	154	28
Carvedilol	Carvedilol	150	32
Zolpidem Tartrate	Zolpidem Tartrate	150	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	145	27
Pravastatin Sodium	Pravastatin Sodium	143	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	36
Albuterol Sulfate Hfa	Albuterol Sulfate	119	29
Donepezil Hcl	Donepezil Hcl	111	22
Lorazepam	Lorazepam	106	19
Prednisone	Prednisone	101	46
Ropinirole Hcl	Ropinirole Hcl	96	14
Xarelto	Rivaroxaban	95	12
Atenolol	Atenolol	90	16
Trazodone Hcl	Trazodone Hcl	90	16
Famotidine	Famotidine	89	20
Citalopram Hbr	Citalopram Hydrobromide	88	11
Allopurinol	Allopurinol	86	27
Duloxetine Hcl	Duloxetine Hcl	86	14
Quetiapine Fumarate	Quetiapine Fumarate	83	suppressed
Fluticasone Propionate	Fluticasone Propionate	79	20
Montelukast Sodium	Montelukast Sodium	76	14
Celecoxib	Celecoxib	72	suppressed
Clopidogrel	Clopidogrel Bisulfate	66	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	64	50
Clonazepam	Clonazepam	62	13
Warfarin Sodium	Warfarin Sodium	62	suppressed
Jardiance	Empagliflozin	61	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	60	suppressed
Ventolin Hfa	Albuterol Sulfate	58	12
Memantine Hcl	Memantine Hcl	57	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	54	suppressed
Oxycodone Hcl	Oxycodone Hcl	53	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Aripiprazole	Aripiprazole	46	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	43	13
Pregabalin	Pregabalin	42	suppressed
Alprazolam	Alprazolam	40	14
Lamotrigine	Lamotrigine	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Sertraline Hcl	Sertraline Hcl	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Spironolactone	Spironolactone	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Amiodarone Hcl	Amiodarone Hcl	34	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Ozempic	Semaglutide	31	suppressed
Trulicity	Dulaglutide	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	14
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	15
Ezetimibe	Ezetimibe	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Topiramate	Topiramate	24	suppressed
Finasteride	Finasteride	23	suppressed
Sucralfate	Sucralfate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	17
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Torsemide	Torsemide	20	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	19	suppressed
Metolazone	Metolazone	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Cephalexin	Cephalexin	18	15
Ibuprofen	Ibuprofen	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	15
Colestipol Hcl	Colestipol Hcl	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Ramipril	Ramipril	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Naproxen	Naproxen	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Single Use Swab	Alcohol Antiseptic Pads	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Primidone	Primidone	11	suppressed
V-Go 40	Sub-Q Insulin Device, 40 Unit	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error